Epclusa 400 MG-100 MG tablet UU 28S
Ended Awarded Last action
- Contract number
- SPE2DR26FG2ZV
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $31,809
Award facts
- Contract value 100% obligated
- $31,808.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $31,808.72 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 7, 2026, for the supply of Epclusa 400 mg-100 mg tablets (28-count units) with delivery expected by January 8, 2026. This competitively awarded, non-set-aside contract is being performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The award represents a task order issued under AmerisourceBergen's parent company, Cencora, Inc., which holds a substantial Indefinite Delivery Contract with DLA Troop Support Medical valued at $999,999,999.00 through December 2031.
This delivery order supports the Defense Logistics Agency's Medical Supply Chain, which procures pharmaceutical products to sustain military healthcare operations globally. Epclusa, an antiviral medication used in hepatitis C treatment, falls within the comprehensive range of specialty pharmaceuticals and brand-name drugs that AmerisourceBergen supplies through its federal contract vehicle. The use of firm fixed-price delivery orders under the larger IDC demonstrates DLA's established relationship with AmerisourceBergen as a qualified pharmaceutical distributor capable of rapidly fulfilling critical medical supply requirements for military treatment facilities and related federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FG2ZV?
SPE2DR26FG2ZV was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26FG2ZV worth?
The government has obligated $31,809 on SPE2DR26FG2ZV.
Is contract SPE2DR26FG2ZV an order under another contract?
Yes. SPE2DR26FG2ZV is a delivery order under SPE2DR25D3016, an indefinite delivery contract.
Was contract SPE2DR26FG2ZV competed?
The extent of competition for SPE2DR26FG2ZV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award